Group One Trading’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,600
| Closed | -$19K | – | 8666 |
|
|
2022
Q2 | $19K | Sell |
12,600
-1,000
| -7% | -$735 | ﹤0.01% | 6348 |
|
|
2022
Q1 | $16K | Sell |
13,600
-18,300
| -57% | -$29.8K | ﹤0.01% | 6932 |
|
|
2021
Q4 | $80K | Buy |
31,900
+30,500
| +2,179% | +$120K | ﹤0.01% | 5930 |
|
|
2021
Q3 | $7K | Sell |
1,400
-1,600
| -53% | -$9.72K | ﹤0.01% | 7665 |
|
|
2021
Q2 | $25K | Hold |
3,000
| – | – | ﹤0.01% | 7063 |
|
|
2021
Q1 | $26K | Sell |
3,000
-12,500
| -81% | -$129K | ﹤0.01% | 6651 |
|
|
2020
Q4 | $168K | Sell |
15,500
-30,800
| -67% | -$380K | ﹤0.01% | 4195 |
|
|
2020
Q3 | $552K | Buy |
46,300
+500
| +1% | +$6.7K | ﹤0.01% | 2757 |
|
|
2020
Q2 | $736K | Buy |
45,800
+44,800
| +4,480% | +$782K | ﹤0.01% | 2312 |
|
|
2020
Q1 | $16K | Sell |
1,000
-1,000
| -50% | -$21.5K | ﹤0.01% | 4364 |
|
|
2019
Q4 | $49K | Buy |
+2,000
| New | +$29.7K | ﹤0.01% | 4017 |
|
|
2019
Q3 | – | Sell |
-42,500
| Closed | -$533K | – | 5724 |
|
|
2019
Q2 | $533K | Buy |
+42,500
| New | +$547K | ﹤0.01% | 2081 |
|
|
2018
Q4 | – | Sell |
-10,800
| Closed | -$114K | – | 5620 |
|
|
2018
Q3 | $114K | Buy |
+10,800
| New | +$123K | ﹤0.01% | 3438 |
|
|
2018
Q2 | – | Sell |
-200
| Closed | -$4K | – | 5615 |
|
|
2018
Q1 | $4K | Sell |
200
-4,900
| -96% | -$82.8K | ﹤0.01% | 4569 |
|
|
2017
Q4 | $64K | Sell |
5,100
-3,300
| -39% | -$48K | ﹤0.01% | 3600 |
|
|
2017
Q3 | $160K | Buy |
8,400
+2,200
| +35% | +$33.6K | ﹤0.01% | 2917 |
|
|
2017
Q2 | $94K | Sell |
6,200
-1,600
| -21% | -$24.2K | ﹤0.01% | 3152 |
|
|
2017
Q1 | $134K | Sell |
7,800
-4,000
| -34% | -$53.3K | ﹤0.01% | 2792 |
|
|
2016
Q4 | $143K | Buy |
11,800
+6,000
| +103% | +$62.6K | ﹤0.01% | 2626 |
|
|
2016
Q3 | $57K | Buy |
5,800
+2,500
| +76% | +$22.8K | ﹤0.01% | 3282 |
|
|
2016
Q2 | $34K | Buy |
3,300
+3,000
| +1,000% | +$33.5K | ﹤0.01% | 3543 |
|
|
2016
Q1 | $4K | Sell |
300
-900
| -75% | -$9.1K | ﹤0.01% | 4266 |
|
|
2015
Q4 | $19K | Sell |
1,200
-15,500
| -93% | -$230K | ﹤0.01% | 3949 |
|
|
2015
Q3 | $215K | Buy |
+16,700
| New | +$337K | ﹤0.01% | 2454 |
|
|
2014
Q4 | – | Sell |
-100
| Closed | -$3K | – | 5400 |
|
|
2014
Q3 | $3K | Hold |
100
| – | – | ﹤0.01% | 4870 |
|
|
2014
Q2 | $3K | Sell |
100
-15,000
| -99% | -$353K | ﹤0.01% | 4943 |
|
|
2014
Q1 | $344K | Buy |
+15,100
| New | +$458K | 0.01% | 1963 |
|
Other funds holding EPZM
Group One Trading's EPZM Position: Q3 2022 in Review
Group One Trading sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 74,339 shares — an estimated $109K sold.
Group One Trading first reported a position in EPZM in Q1 2014 and held it in 19 quarters. The position peaked at $304K in Q1 2014. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Group One Trading reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Group One Trading sold 74,339 Epizyme, Inc shares in Q3 2022, an estimated $109K.
- Group One Trading first reported a position in Epizyme, Inc in Q1 2014 and held it in 19 quarters.
- Group One Trading's Epizyme, Inc position peaked at $304K in Q1 2014.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.